Gyre Therapeutics Inc.
GYRE | NASDAQ
$5.06
+$0.50 (+11.09%)
Nov 2, 2026, 9:53 AM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 119.38M | 120.01M | 119.55M | 110.23M | 105.15M | 100.64M | 105.76M | 105.03M | 111.59M | 115.69M | 113.45M | 114.78M | 111.91M | 82.58M | 58.44M | 32.4M | 5.53M | 6.67M | 7.34M | 6.93M | 5.52M | 6.05M |
Cost of Revenue | 6.81M | 5.75M | 5.42M | 4.85M | 4.18M | 3.8M | 3.88M | 3.96M | 4.18M | 4.49M | 4.64M | 4.75M | 4.96M | 3.95M | 3.73M | 4.82M | 5.82M | 6.94M | 7.51M | 7.13M | 5.65M | 6.21M |
Gross Profit | 112.58M | 114.26M | 114.14M | 105.38M | 100.97M | 96.84M | 101.87M | 101.08M | 107.4M | 111.2M | 108.81M | 110.03M | 106.95M | 78.63M | 54.71M | 27.58M | -291K | -276K | -172K | -203K | -128K | -160K |
Operating Income | -16.67M | -4.55M | 7.08M | 7.62M | 4.93M | 10.43M | 16.23M | -76.07M | -67.54M | -65.82M | -67.23M | 29M | 20.84M | 10.15M | -11.21M | -36.13M | -65.96M | -80.16M | -87.89M | -86.42M | -77.29M | -74.74M |
Interest Income | 1.45M | 1.65M | 1.85M | 1.69M | 2.01M | 1.42M | 1.55M | 1.53M | 1.29M | 1.19M | 1.04M | 885K | 885K | 719K | 537K | 374K | 98K | 24K | 39K | 60K | 127K | 244K |
Pretax Income | -16.11M | -3.25M | 10.62M | 11.46M | 7.76M | 15.37M | 23.22M | -77.83M | -70.57M | -70.76M | -76.97M | 22.17M | 10.02M | 55.8M | 34.99M | 15.8M | -8.47M | -80.03M | -87.93M | -86.51M | -77.31M | -74.63M |
Net Income | -17.33M | -6.13M | 5.18M | 6.81M | 4.32M | 7.25M | 12.09M | -88.82M | -85.97M | -87.65M | -92.93M | 4.59M | -2.72M | 47.06M | 30.28M | 13.43M | -8.47M | -80.03M | -87.93M | -86.51M | -77.31M | -74.63M |
Selling & General & Admin | 93.14M | 93.99M | 88.43M | 80.24M | 78.11M | 73.48M | 73.62M | 77.82M | 75.38M | 77.25M | 75.82M | 71.58M | 79.2M | 63.33M | 53.82M | 35.7M | 17.87M | 18.55M | 18.96M | 19.08M | 18.05M | 17.9M |
Research & Development | 33.05M | 22.27M | 18.62M | 17.52M | 17.93M | 12.94M | 12.02M | 12.88M | 13.11M | 13.33M | 13.78M | 15.43M | 18.7M | 16.94M | 23.9M | 33.81M | 47.8M | 61.34M | 68.76M | 67.14M | 59.12M | 56.68M |
Other Expenses | 3.06M | 2.55M | 1K | 67K | 66K | 66K | 66K | 86.44M | 86.44M | 86.44M | 86.44M | -5.98M | -11.79M | -11.79M | -11.79M | -5.82M | -20K | -20K | -37K | -17K | -24K | -39K |
Operating Expenses | 129.25M | 118.81M | 107.06M | 97.82M | 96.11M | 86.48M | 85.71M | 177.14M | 174.94M | 177.02M | 176.04M | 81.03M | 86.11M | 68.48M | 65.92M | 63.71M | 65.67M | 79.88M | 87.72M | 86.22M | 77.17M | 74.58M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 716K | 717K | 717K | 717K | 1K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | 67.03M | 68.48M | 65.18M | 58.22M | 56.59M | 55.81M | 57.51M | 57.12M | 57.35M | 60.93M | 61.16M | 60.13M | 62M | 44M | 31.23M | 15.79M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 136.06M | 124.56M | 112.47M | 102.61M | 100.22M | 90.21M | 89.53M | 181.1M | 179.12M | 181.51M | 180.68M | 85.78M | 91.07M | 72.43M | 69.66M | 68.53M | 71.49M | 86.82M | 95.23M | 93.35M | 82.82M | 80.79M |
Income Tax Expense | 2.21M | 3.03M | 4.56M | 3.46M | 2.84M | 3.68M | 5.32M | 5.82M | 8.42M | 9.01M | 8.51M | 9.15M | 6.84M | 4.76M | 2.7M | 1.37M | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 100.64M | 91.32M | 91.16M | 89.12M | 89.12M | 86.42M | 85.09M | 85.64M | 85.5M | 83.27M | 76.6M | 76.6M | 69.95M | 69.95M | 63.3M | 61.05M | 62.94M | 46.79M | 31.42M | 31.38M | 31.14M | 28.39M |
Shares Outstanding (Diluted) | 100.64M | 91.34M | 102.94M | 102.7M | 89.2M | 101.97M | 102.29M | 102.64M | 104.33M | 102.59M | 76.6M | 76.6M | 70.09M | 70.09M | 63.59M | 61.05M | 62.94M | 46.79M | 31.42M | 31.38M | 31.35M | 28.39M |
EPS (Basic) | -0.20 | -0.10 | 0.03 | 0.05 | 0.02 | 0.08 | 0.14 | -1.25 | -1.21 | -1.22 | -1.28 | 0.06 | -0.05 | 0.75 | 0.40 | -0.19 | -0.94 | -2.40 | -2.88 | -3.08 | -3.01 | -3.33 |
EPS (Diluted) | -0.20 | -0.11 | -0.01 | 0.01 | -0.02 | 0.04 | 0.11 | -1.27 | -1.23 | -1.24 | -1.28 | 0.05 | -0.06 | 0.74 | 0.40 | -0.19 | -0.94 | -2.40 | -2.88 | -3.08 | -3.01 | -3.33 |
EBITDA | -14.03M | -889K | 12.85M | 13.35M | 9.48M | 16.98M | 24.71M | 18.69M | 25.68M | 25.58M | 19.24M | 22.97M | 10.62M | -1.2M | -22.35M | -41.39M | -65.59M | -79.82M | -87.63M | -86.29M | -77.2M | -74.54M |
EBIT | -16.11M | -3.91M | 9.96M | 10.69M | 6.99M | 15.26M | 23.11M | 17.26M | 24.52M | 24.33M | 18.12M | 21.93M | 9.54M | -2.03M | -23M | -41.95M | -65.98M | -80.2M | -87.93M | -86.51M | -77.31M | -74.63M |
Depreciation & Amortization | 2.08M | 3.03M | 2.89M | 2.66M | 2.49M | 1.72M | 1.6M | 1.44M | 1.16M | 1.24M | 1.11M | 1.04M | 1.08M | 825.95K | 652.95K | 536.56K | 380K | 358K | 290K | 220K | 177K | 158K |
Add to Watchlist
Select watchlists to add or remove GYRE